Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORC1 c.-1639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients
| dc.contributor.author | Verde Rello, Zoraida | |
| dc.contributor.author | Santiago Dorrego, Catalina | |
| dc.contributor.author | Valle Borrego, Beatriz | spa |
| dc.contributor.author | Fernández Santander, Ana | |
| dc.contributor.author | Bandrés Moya, Fernando | spa |
| dc.contributor.author | Calvo, Elpidio | spa |
| dc.contributor.author | Ruiz, Jonatan R. | spa |
| dc.contributor.author | Lucía Mulas, Alejandro | |
| dc.contributor.author | Gallego, Fe | spa |
| dc.date.accessioned | 2013-11-27T17:25:55Z | |
| dc.date.available | 2013-11-27T17:25:55Z | |
| dc.date.issued | 2009 | spa |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 4.451 JCR (2009) Q1, 14/61 Hematology, 11/61 Peripheral vascular disease | spa |
| dc.identifier.citation | Verde-Rello, Z., Santiago-Dorrego, C., Valle-Borrego, B., Fernández-Santander, A., Bandrés, F., Calvo, E., ..., & Gómez-Gallego, F. (2009). Pharmacogenetics of acenocoumarol: CYP2C9* 2 and VKORC1 c.-1639G> A, 497C> G, 1173C> T, and 3730G> A variants influence drug dose in anticoagulated patients. Thromb Haemost,101, 591-593. | spa |
| dc.identifier.doi | 10.1160/TH08-09-0578 | spa |
| dc.identifier.issn | 03406245 | spa |
| dc.identifier.uri | http://hdl.handle.net/11268/293 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.rights.accessRights | restricted access | en |
| dc.subject.other | Anticoagulants/*Pharmacokinetics | spa |
| dc.subject.other | Aryl Hydrocarbon Hydroxylases/*Genetics | spa |
| dc.subject.other | Mixed Function Oxygenases/*Genetics | spa |
| dc.subject.other | Anticoagulants/Administration & Dosage | spa |
| dc.subject.other | Female | spa |
| dc.subject.other | Humans | spa |
| dc.subject.other | Male | spa |
| dc.subject.other | Middle Aged | spa |
| dc.subject.other | Polymorphism, Genetic | spa |
| dc.subject.other | Risk Factors | spa |
| dc.subject.unesco | Farmacología | spa |
| dc.title | Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORC1 c.-1639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 6ce54358-54bd-43cc-9234-e507e38f678a | |
| relation.isAuthorOfPublication | 747003ff-e813-4d18-861a-fe3db500ab6c | |
| relation.isAuthorOfPublication | 8f0ff816-e791-403f-901d-e479575cf9e8 | |
| relation.isAuthorOfPublication | d3691359-d7bd-4a12-b84e-338e28c81f9f | |
| relation.isAuthorOfPublication.latestForDiscovery | 6ce54358-54bd-43cc-9234-e507e38f678a |

